Funding
Luma Vision raises $22m, seeks FDA clearance for cardiac imaging platform
Company formerly known as OneProjects has raised over $50m to date for its groundbreaking platform
Luma Vision, an Irish-German medtech start-up specialising in cardiac imaging solutions, has secured a further $22 million (€20 million) in financing to help it secure FDA approval for its Verafeye platform.
Founded by Fionn Lahart and Christoph Hennersperger in 2017, the company, which has raised over $50 million to date, was formerly known as OneProjects.
Luma is focusing on facilitating the treatment of cardiac arrhythmias such as atrial fibrillation (AFib). It has developed a novel ...
